Your browser doesn't support javascript.
loading
Favorable response to nivolumab in a young adult patient with metastatic histiocytic sarcoma.
Bose, Shree; Robles, Joanna; McCall, Chad M; Lagoo, Anand S; Wechsler, Daniel S; Schooler, Gary R; Van Mater, David.
Afiliação
  • Bose S; School of Medicine, Duke University Medical Center, Durham, North Carolina.
  • Robles J; Division of Pediatric Hematology-Oncology, Department of Pediatrics, Duke University Medical Center, Durham, North Carolina.
  • McCall CM; Department of Pathology, Duke University Medical Center, Durham, North Carolina.
  • Lagoo AS; Department of Pathology, Duke University Medical Center, Durham, North Carolina.
  • Wechsler DS; Aflac Cancer & Blood Disorders Center, Children's Healthcare of Atlanta, Emory University Department of Pediatrics, Atlanta, Georgia.
  • Schooler GR; Department of Radiology, Duke University Medical Center, Durham, North Carolina.
  • Van Mater D; Division of Pediatric Hematology-Oncology, Department of Pediatrics, Duke University Medical Center, Durham, North Carolina.
Pediatr Blood Cancer ; 66(1): e27491, 2019 01.
Article em En | MEDLINE | ID: mdl-30270506
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias Ósseas / Sarcoma Histiocítico / Antineoplásicos Imunológicos / Nivolumabe Tipo de estudo: Prognostic_studies Limite: Adolescent / Female / Humans Idioma: En Ano de publicação: 2019 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias Ósseas / Sarcoma Histiocítico / Antineoplásicos Imunológicos / Nivolumabe Tipo de estudo: Prognostic_studies Limite: Adolescent / Female / Humans Idioma: En Ano de publicação: 2019 Tipo de documento: Article